Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCarclo Regulatory News (CAR)

Share Price Information for Carclo (CAR)

Share Price is delayed by 15 minutes
Get Live Data
35.70    0.00 (0.00%)
Bid:
35.00
Ask:
36.00
Spread: 1.00 (2.857%)
Market Cap: £26.21m
CAR Live PriceLast checked at - London Stock Exchange

Intraday Carclo Share Chart

Trading Update

5 Sep 2024 07:00

RNS Number : 9408C
Carclo plc
05 September 2024
 

05 September 2024

 

 

Carclo plc

 

Trading Update

Carclo plc, the leading global provider of high-precision components, offering comprehensive services from mould design, automation and production to assembly and printing, serving the life sciences, aerospace, optics and tech sectors, provides the following trading update ahead of our AGM.

Financial Performance

Our strategic focus on improving our balance sheet, enhancing asset utilisation, prioritising margin over volume, and maximising our global footprint continues to yield positive results.

The Group's trading performance year to date is in line with management's expectations. The US manufacturing rationalisation and improvement programme is on track. By focussing on cash management and leveraging stronger trading, we have further improved our net debt to uEBITDA ratio. This progress highlights our unwavering commitment to strengthening our financial health across all operations.

Our expectations for the FY25 full year and FY26 remain unchanged with margin expansion anticipated to continue as the Group starts to see the full benefits of the operational optimisation process, continuing our journey toward our strategic goals of 10% return on sales and 25% return on capital employed.

CTP Design & Engineering

Our CTP Design & Engineering division maintains its focus on asset revitalisation projects, which are crucial for driving the next phase of operational improvements. This strategic emphasis underlines our commitment to sustainably enhancing overall company performance and meeting the evolving needs of our clients. These efforts continue to strengthen Carclo's leadership position in the sector, with a clear vision for sustained, medium-term growth.

CTP US Manufacturing Solutions

The restructuring of our US operations is progressing ahead of schedule, as highlighted during our full-year results presentation. We have successfully completed final production runs in Tucson and are now fully focused on our operational turnaround strategy at our centralised facility in Pennsylvania.

New leadership teams in our specialised production cells are beginning to drive important improvements in asset utilisation and operational performance, which are leading to the expected enhancement in margins. These proactive measures position us well to address short-term challenges while keeping our eyes on the medium to long-term strategic goals.

CTP EMEA Manufacturing Solutions

Our CTP EMEA Manufacturing Solutions division continues to build on its strong performance as we focus on the next phase of operational improvement through material and process optimisation. Following the new operational setup in EMEA, the region has emerged even stronger, with lasting enhancements in operational efficiency.

We have achieved an optimal balance of efficiency and flexibility by establishing long-run operations in the UK and medium-flexible runs at our facility in the Czech Republic, which enables us to effectively meet the growing demands of the EMEA market.

Speciality Division

We have now combined our Aerospace and Specialised Optics businesses into our Speciality Division, dedicated to providing customised solutions for niche markets. Both sectors utilise a strong market position built on specialised precision components, ongoing innovation, and exceptional customer support. The Aerospace sector, in particular, has continued its growth trajectory, showcasing the success of our strategic initiatives and commitment to precision leadership. Our expanding precision machining capabilities have enhanced our product offerings, further strengthening Carclo's respected position in the aerospace industry. These accomplishments reflect our steadfast commitment to quality and innovation across all specialty operations.

Further details will be provided in our interim results for the six months ending 30 September 2024, which will be released later this year.

 

LEI: 21380078MEM399JPI956

 

Enquiries:

Carclo plc +44 (0) 20 8685 0500

Frank Doorenbosch Chief Executive Officer

Eric Hutchinson Chief Financial Officer

 

 

Forward-looking statements

 

Certain statements made in this announcement are forward-looking statements. Such statements are based on current expectations and are subject to a number of risks and uncertainties that could cause outcomes to differ materially from those expected.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFFEAFISIIS
Date   Source Headline
7th Jun 20167:00 amRNSFinal Results
16th May 20167:00 amRNSIntended Exit from Carclo Diagnostics Solutions
12th Feb 20164:40 pmRNSSecond Price Monitoring Extn
12th Feb 20164:35 pmRNSPrice Monitoring Extension
10th Feb 20164:41 pmRNSSecond Price Monitoring Extn
10th Feb 20164:36 pmRNSPrice Monitoring Extension
4th Feb 20167:00 amRNSInterim Management Statement
17th Nov 20157:00 amRNSHalf Yearly Report
16th Oct 20153:58 pmRNSHolding(s) in Company
15th Oct 20157:00 amRNSHalf Year Trading Update
4th Sep 201510:20 amRNSResult of AGM
3rd Sep 20157:00 amRNSAGM Statement
15th Jul 20157:00 amRNSPerformance Share Plan
10th Jul 20153:37 pmRNSHolding(s) in Company
12th Jun 20159:59 amRNSHolding(s) in Company
10th Jun 20153:18 pmRNSDirector/PDMR Shareholding
9th Jun 20157:00 amRNSFinal Results
1st Jun 20157:00 amRNSHolding(s) in Company
17th Apr 20157:00 amRNSAnnouncement of CIT Technology Licensing Agreement
9th Apr 20157:00 amRNSYear End Trading Update
1st Apr 20157:00 amRNSDirectorate Change
31st Mar 20157:00 amRNSRefinancing
26th Mar 20157:00 amRNSDirectorate Change
19th Mar 20157:00 amRNSCourt confirms Capital Reduction
11th Mar 20154:41 pmRNSHolding(s) in Company
25th Feb 20153:50 pmRNSResult of General Meeting
11th Feb 20153:02 pmRNSHolding(s) in Company
10th Feb 201512:09 pmRNSHolding(s) in Company
10th Feb 20159:41 amRNSHolding(s) in Company
9th Feb 20157:00 amRNSNotice of General Meeting
5th Feb 20157:00 amRNSInterim Management Statement
22nd Dec 20144:37 pmRNSHolding(s) in Company
12th Dec 201411:59 amRNSHolding(s) in Company
18th Nov 20147:00 amRNSAppointment of Corporate Broker
18th Nov 20147:00 amRNSHalf Yearly Report
10th Oct 20147:00 amRNSHalf Year Trading Update
4th Sep 20143:30 pmRNSResult of AGM
14th Aug 20147:00 amRNSInterim Management Statement
7th Aug 20147:00 amRNSAtmel Corporation Announcement
14th Jul 20147:00 amRNSPerformance Share Plan
18th Jun 20147:00 amRNSDirector/PDMR Shareholding
12th Jun 201410:14 amRNSHolding(s) in Company
10th Jun 20147:00 amRNSFinal Results
1st May 20147:00 amRNSAtmel Corporation and Trading Update
9th Apr 20142:10 pmRNSHolding(s) in Company
7th Apr 20147:00 amRNSYear End Trading Update
3rd Apr 20143:38 pmRNSCIT settlement of Litigation with Uni-Pixel
6th Feb 20142:40 pmRNSDirector/PDMR Shareholding
6th Feb 20147:00 amRNSAtmel Corporation Announcement
22nd Jan 20147:00 amRNSInterim Management Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.